Tennessee Clinical Trials

Recruiting studies in Tennessee

• A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System
  NCT07194265NAAnteris Technologies Ltd.Severe Aortic StenosisGermantown, TN
• A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
  NCT06972446PHASE2AbbVieRheumatoid ArthritisJackson, TN
• ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
  NCT07173751PHASE3BioNTech SEBreast NeoplasmsGermantown, TN
• Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
  NCT06393374PHASE3Merck Sharp & Dohme LLCTriple-Negative Breast CancerGermantown, TN
• A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
  NCT05828069PHASE2National Cancer Institute (NCI)Recurrent Langerhans Cell HistiocytosisKnoxville, TN
• A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
  NCT05711394PHASE3AbbVieEpisodic MigraineMemphis, TN
• LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
  NCT07415044PHASE2Eli Lilly and CompanyUlcerative Colitis (UC)Jackson, TN
• Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
  NCT06847321PHASE2Lighthouse Pharmaceuticals, Inc.Alzheimer DiseaseNashville, TN
• A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
  NCT06136650PHASE3Merck Sharp & Dohme LLCMetastatic Castration-resistant Prostate Cancer (mCRPC)Germantown, TN
• A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
  NCT07100106PHASE1, PHASE2Genentech, Inc.Breast CancerNashville, TN
• A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
  NCT07059845PHASE2AbbVieOvarian CancerKnoxville, TN
• Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
  NCT06136624PHASE3Merck Sharp & Dohme LLCProstate Cancer MetastaticNashville, TN

See all 1,880 recruiting trials →

Clinical trials by Tennessee metro

• Nashville
• Memphis

Popular conditions in Tennessee

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Tennessee?

Corterve aggregates actively recruiting clinical trials with sites in Tennessee from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.

Are clinical trials in Tennessee free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What kinds of clinical trials are available in Tennessee?

Tennessee research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.